(Q44904193)

7 December 2017

title

MTHFR T677 homozygosis influences the presence of aura in migraineurs (English)

1 reference

7 December 2017

Oterino A

1

1 reference

7 December 2017

Valle N

2

1 reference

7 December 2017

Bravo Y

3

1 reference

7 December 2017

Muñoz P

4

1 reference

7 December 2017

Sánchez-Velasco P

5

1 reference

7 December 2017

Ruiz-Alegría C

6

1 reference

7 December 2017

Castillo J

7

1 reference

7 December 2017

Leyva-Cobián F

8

1 reference

7 December 2017

Vadillo A

9

1 reference

7 December 2017

Pascual J

10

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

24

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

491-494

1 reference

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Search for Mitochondrial Dna Mutations in Migraine Subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Is blood homocysteine elevated in migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Association between migraine and stroke in a large-scale epidemiological study of the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00692.X

10.1111/J.1468-2982.2004.00692.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference